Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-25-292412 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
29.41% · OPTIONAL · VALID
Capex intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.38% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.91% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-7.04% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.57% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
25.32% · CORE · VALID
Operating margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.73% · CORE · VALID
R&D intensity 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.59% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.65% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 131.64%
Current 29.41%
Delta -102.23% Capex Intensity Increased
Previous 6.61%
Current 7.38%
Delta 0.77% Cash Generation Decreased
Previous 26.98%
Current 17.91%
Delta -9.07% Growth Increased
Previous -9.15%
Current -7.04%
Delta 2.12% Inventory Pressure Decreased
Previous 57.53%
Current 13.57%
Delta -43.96% Margin Decreased
Previous 26.44%
Current 25.32%
Delta -1.12% Profitability Decreased
Previous 18.09%
Current 16.73%
Delta -1.37% R And D Intensity Decreased
Previous 1.63%
Current 1.59%
Delta -0.04% Sbc Intensity Increased
Previous 0.54%
Current 0.65%
Delta 0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.